Scientific Article
previous document  unige:43811  next document
add to browser collection
Title

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility

Authors
Hai, Rong
Leyva-Grado, Victor H
Thangavel, Rajagowthamee R
Margine, Irina
Jaffe, Eric L
Krammer, Florian
Solórzano, Alicia
show hidden authors show all authors [1 - 11]
Published in Nature Communications. 2013, vol. 4, p. 2854
Abstract Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections. An amino acid change in the viral neuraminidase associated with drug resistance, NA-R292K (N2 numbering), has been found in some H7N9 clinical isolates. Here we assess the impact of the NA-R292K substitution on antiviral sensitivity and viral replication, pathogenicity and transmissibility of H7N9 viruses. Our data indicate that an H7N9 isolate encoding the NA-R292K substitution is highly resistant to oseltamivir and peramivir and partially resistant to zanamivir. Furthermore, H7N9 reassortants with and without the resistance mutation demonstrate comparable viral replication in primary human respiratory cells, virulence in mice and transmissibility in guinea pigs. Thus, in stark contrast to oseltamivir-resistant seasonal influenza A(H3N2) viruses, H7N9 virus replication and pathogenicity in these models are not substantially altered by the acquisition of high-level oseltamivir resistance due to the NA-R292K mutation.
Identifiers
PMID: 24326875
Full text
Article (Published version) (346 Kb) - public document Free access
Citation
(ISO format)
HAI, Rong et al. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. In: Nature Communications, 2013, vol. 4, p. 2854. https://archive-ouverte.unige.ch/unige:43811

113 hits

40 downloads

Update

Deposited on : 2014-12-18

Export document
Format :
Citation style :